Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction.

scientific article published in May 1990

Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0735-1097(10)80029-4
P698PubMed publication ID2329241

P2093author name stringR Virmani
C Gold
G L Schaer
M S Visner
E C Santoian
S P Karas
P2860cites workPlatelet trapping in myocardial infarct in baboons: therapeutic effect of aspirinQ71322367
Fluorocarbons reduce myocardial ischemic damage after coronary occlusionQ71492786
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dogQ71682222
Kinetics and imaging of indium-11-labeled autologous platelets in experimental myocardial infarctionQ71726137
The use of single plane angiocardiograms for the calculation of left ventricular volume in manQ72023273
Myocardial reperfusion: a double-edged sword?Q28236054
Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarctionQ33821794
The "no-reflow" phenomenon after temporary coronary occlusion in the dog.Q34471387
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacologyQ34606745
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesionQ35810373
Can superoxide dismutase alter myocardial infarct size?Q38625209
Myocardial platelet trapping after coronary ligation in primates (Papio anubis).Q39666842
Amphipathic metabolites and membrane dysfunction in ischemic myocardiumQ40076674
The stunned myocardium: prolonged, postischemic ventricular dysfunctionQ40246508
Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.Q44293269
Distal coronary artery perfusion during percutaneous transluminal coronary angioplastyQ44498506
Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion modelQ47196223
Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heartQ47196496
Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusionQ47204619
Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardiumQ47208118
Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusionQ47225571
Effect of fluocarbon exchange transfusion on myocardial infarction size in dogsQ47252441
Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniqueQ47282887
Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.Q51827797
Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.Q54105007
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.Q64997881
Complement and neutrophil activation in the pathogenesis of ischemic myocardial injuryQ67969208
Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivoQ68091009
Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activationQ69329614
Oxygen consumption and coronary reactivity in postischemic myocardiumQ69934332
Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusionsQ70021482
Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusionQ70055416
Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusionQ70058758
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trialQ70331348
Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensionsQ70361804
The interactions of platelet-derived mediators on isolated canine coronary arteriesQ70511432
Role of free radicals in catecholamine-induced cardiomyopathyQ70538562
Effects of perfluorochemical on phagocytic function of leukocytesQ71119675
Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservationQ71257162
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
reperfusion injuryQ1413991
P304page(s)1385-1393
P577publication date1990-05-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleReduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction.
P478volume15

Reverse relations

cites work (P2860)
Q48833015Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery
Q40588885Cardiovascular applications of fluorocarbons in regional ischemia/reperfusion
Q47241818Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion
Q40466595Fluorocarbon emulsions
Q35185199Myocardial Oxygen Supply under Critical Conditions, the Effects of Hemodilution and Fluorocarbons
Q35684768Myocardial protection during coronary angioplasty

Search more.